Inmedical Therapeutics

www.inmedicaltherapeutics.com ↗ ·Vitoria-Gasteiz ·Seed

Inmedical Therapeutics is a Spanish medical device company based in Vitoria-Gasteiz, founded in 2020, developing Covergel, a bioadhesive thermosensitive hydrogel (Class III device) that forms a protective barrier over colonoscopic resection wounds to accelerate mucosal healing and prevent complications such as delayed bleeding or perforation. It closed an €800,000 seed round in January 2024 with Viscofan and the Basque public venture fund (Grupo SPRI), and has completed preclinical work while running clinical trials in Basque hospitals ahead of a targeted 2025 commercialization.

Founded

2020

Founders

Total funds raised

€800K

SectorsMedical Devices, Biotech, Gastroenterology, Wound Care Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Suggest a correction

Founders

Luciano Conde Conde

Founder

Also at Medex Partners →

Global models 5

Tissium

France · www.tissium.com ↗

Develops a bioresorbable polymer platform for surgical sealants and tissue-repair adhesives, the closest large-scale analog to Inmedical's bioadhesive hydrogel tissue-healing approach.

$138MComparable

Cresilon

United States · www.cresilon.com ↗

Plant-based hemostatic gel used to rapidly stop bleeding in surgical and wound-care settings, matching the wound-protection/anti-bleeding function of Covergel.

$90M+Comparable

Cohera Medical

United States · www.coheramedical.com ↗

Developed TissuGlu, a surgical tissue adhesive for internal wound closure and healing, later acquired by Sanofi, similar in model to Inmedical's internal-tissue bioadhesive device.

$80M+Comparable

Arch Therapeutics

United States · www.archtherapeutics.com ↗

Makes AC5, a self-assembling peptide hydrogel applied to internal wounds to control bleeding and support healing, directly comparable to Covergel's hydrogel wound-protection mechanism.

$50M+Comparable

GATT Technologies

Netherlands · www.gatt-technologies.com ↗

Develops a hemostatic patch/hydrogel platform for surgical and endoscopic bleeding control, targeting a similar clinical use case to Inmedical's endoscopy-focused device.

$25M+Comparable